Text Size

Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation

This study is currently recruiting participants.
Verified August 2009 by Komagome Hospital
Sponsor:
Information provided by:
Komagome Hospital
ClinicalTrials.gov Identifier:
NCT00452205
First received: March 26, 2007
Last updated: August 3, 2009
Last verified: August 2009
History of Changes
  Purpose

The purpose of this study is to clarify the relationship bone marrow-derived cells and the formation of the tumors, and the role of these cells in regeneration of epithelial cells in the gastrointestinal tract.


Condition
Gastrointestinal Neoplasms

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Bone Marrow-derived Cells' Contribution to Tumor Formation and Epithelial Cells Regeneration in the Gastrointestinal Tract

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Komagome Hospital:

Biospecimen Retention:   Samples With DNA

tissue


Estimated Enrollment: 300
Study Start Date: April 2007
Estimated Study Completion Date: March 2017
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   20 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients received bone marrow transplantation in Tokyo Metropolitan Komagome Hospital

Criteria

Inclusion Criteria:

  • After allogeneic bone marrow transplantation

Exclusion Criteria:

  • Contraindication for gastrointestinal endoscopy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00452205

Contacts
Contact: Naoto Egawa, MD +81-3-3823-2101 ext 6158 naoto@cick.jp
Contact: Hisashi Sakamaki, MD +81-3-3823-2101 ext 6153 sakamaki@cick.jp

Locations
Japan
Cancer and Infection Disease Center, Komagome Recruiting
Tokyo, Bunkyo-ku, Japan, 113-8677
Contact: Naoto Egawa, MD     +81-3-3823-2101 ext 6158     naoto@cick.jp    
Contact: Hisashi Sakamaki, MD     +81-3-3823-2101 ext 6153     sakamaki@cick.jp    
Principal Investigator: Naoto Egawa, MD            
Sponsors and Collaborators
Komagome Hospital
Investigators
Study Director: Naoto Egawa, MD
  More Information

Publications:

Responsible Party: Naoto Egawa, Tokyo Metropolitan Komagome Hospital
ClinicalTrials.gov Identifier: NCT00452205     History of Changes
Other Study ID Numbers: CICK-07521
Study First Received: March 26, 2007
Last Updated: August 3, 2009
Health Authority: Japan: Institutional Review Board

Keywords provided by Komagome Hospital:
bone marrow-derived stem cell
bone marrow transplantation
graft versus host disease
gastrointestinal cancer
after receiving bone marrow transplantation

Additional relevant MeSH terms:
Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
 Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases

ClinicalTrials.gov processed this record on May 16, 2013